Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

TRNR vs HIMS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TRNR
Interactive Strength Inc.

Personal Products & Services

Consumer CyclicalNASDAQ • US
Market Cap$2M
5Y Perf.-100.0%
HIMS
Hims & Hers Health, Inc.

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$6.63B
5Y Perf.+121.4%

TRNR vs HIMS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TRNR logoTRNR
HIMS logoHIMS
IndustryPersonal Products & ServicesMedical - Equipment & Services
Market Cap$2M$6.63B
Revenue (TTM)$10M$2.35B
Net Income (TTM)$-20M$128M
Gross Margin-0.8%69.7%
Operating Margin-228.0%4.6%
Forward P/E51.5x
Total Debt$12M$1.12B
Cash & Equiv.$138K$229M

TRNR vs HIMSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TRNR
HIMS
StockApr 23May 26Return
Interactive Strengt… (TRNR)1000.0-100.0%
Hims & Hers Health,… (HIMS)100221.4+121.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: TRNR vs HIMS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HIMS leads in 4 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Interactive Strength Inc. is the stronger pick specifically for growth and revenue expansion. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
TRNR
Interactive Strength Inc.
The Growth Play

TRNR is the clearest fit if your priority is growth exposure.

  • Rev growth 459.3%, EPS growth 1.7%, 3Y rev CAGR 155.4%
  • 459.3% revenue growth vs HIMS's 59.0%
Best for: growth exposure
HIMS
Hims & Hers Health, Inc.
The Income Pick

HIMS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • beta 2.40
  • 161.9% 10Y total return vs TRNR's -100.0%
  • Lower volatility, beta 2.40, current ratio 1.90x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthTRNR logoTRNR459.3% revenue growth vs HIMS's 59.0%
Quality / MarginsHIMS logoHIMS5.5% margin vs TRNR's -202.4%
Stability / SafetyHIMS logoHIMSBeta 2.40 vs TRNR's 2.40
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)HIMS logoHIMS-51.0% vs TRNR's -98.6%
Efficiency (ROA)HIMS logoHIMS6.0% ROA vs TRNR's -32.5%, ROIC 10.7% vs -188.2%

TRNR vs HIMS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHIMSLAGGINGTRNR

Income & Cash Flow (Last 12 Months)

HIMS leads this category, winning 4 of 6 comparable metrics.

HIMS is the larger business by revenue, generating $2.3B annually — 240.2x TRNR's $10M. HIMS is the more profitable business, keeping 5.5% of every revenue dollar as net income compared to TRNR's -2.0%. On growth, TRNR holds the edge at +139.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricTRNR logoTRNRInteractive Stren…HIMS logoHIMSHims & Hers Healt…
RevenueTrailing 12 months$10M$2.3B
EBITDAEarnings before interest/tax-$16M$164M
Net IncomeAfter-tax profit-$20M$128M
Free Cash FlowCash after capex-$59M$73M
Gross MarginGross profit ÷ Revenue-0.8%+69.7%
Operating MarginEBIT ÷ Revenue-2.3%+4.6%
Net MarginNet income ÷ Revenue-2.0%+5.5%
FCF MarginFCF ÷ Revenue-6.1%+3.1%
Rev. Growth (YoY)Latest quarter vs prior year+139.1%+28.4%
EPS Growth (YoY)Latest quarter vs prior year+73.5%-27.3%
HIMS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

TRNR leads this category, winning 3 of 3 comparable metrics.
MetricTRNR logoTRNRInteractive Stren…HIMS logoHIMSHims & Hers Healt…
Market CapShares × price$2M$6.6B
Enterprise ValueMkt cap + debt − cash$13M$7.5B
Trailing P/EPrice ÷ TTM EPS-0.00x50.32x
Forward P/EPrice ÷ next-FY EPS est.51.51x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple42.68x
Price / SalesMarket cap ÷ Revenue0.34x2.82x
Price / BookPrice ÷ Book value/share0.00x12.25x
Price / FCFMarket cap ÷ FCF89.61x
TRNR leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

Evenly matched — TRNR and HIMS each lead in 4 of 8 comparable metrics.

HIMS delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-145 for TRNR. TRNR carries lower financial leverage with a 1.65x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.07x. On the Piotroski fundamental quality scale (0–9), TRNR scores 7/9 vs HIMS's 4/9, reflecting strong financial health.

MetricTRNR logoTRNRInteractive Stren…HIMS logoHIMSHims & Hers Healt…
ROE (TTM)Return on equity-144.9%+23.7%
ROA (TTM)Return on assets-32.5%+6.0%
ROICReturn on invested capital-188.2%+10.7%
ROCEReturn on capital employed-22.8%+10.9%
Piotroski ScoreFundamental quality 0–974
Debt / EquityFinancial leverage1.65x2.07x
Net DebtTotal debt minus cash$12M$892M
Cash & Equiv.Liquid assets$138,000$229M
Total DebtShort + long-term debt$12M$1.1B
Interest CoverageEBIT ÷ Interest expense-0.76x
Evenly matched — TRNR and HIMS each lead in 4 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

HIMS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in HIMS five years ago would be worth $23,764 today (with dividends reinvested), compared to $0 for TRNR. Over the past 12 months, HIMS leads with a -51.0% total return vs TRNR's -98.6%. The 3-year compound annual growth rate (CAGR) favors HIMS at 29.4% vs TRNR's -99.0% — a key indicator of consistent wealth creation.

MetricTRNR logoTRNRInteractive Stren…HIMS logoHIMSHims & Hers Healt…
YTD ReturnYear-to-date-90.1%-23.2%
1-Year ReturnPast 12 months-98.6%-51.0%
3-Year ReturnCumulative with dividends-100.0%+116.6%
5-Year ReturnCumulative with dividends-100.0%+137.6%
10-Year ReturnCumulative with dividends-100.0%+161.9%
CAGR (3Y)Annualised 3-year return-99.0%+29.4%
HIMS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

HIMS leads this category, winning 2 of 2 comparable metrics.

HIMS is the less volatile stock with a 2.40 beta — it tends to amplify market swings less than TRNR's 2.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HIMS currently trades 36.4% from its 52-week high vs TRNR's 0.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTRNR logoTRNRInteractive Stren…HIMS logoHIMSHims & Hers Healt…
Beta (5Y)Sensitivity to S&P 5002.40x2.40x
52-Week HighHighest price in past year$126.00$70.43
52-Week LowLowest price in past year$0.61$13.74
% of 52W HighCurrent price vs 52-week peak+0.7%+36.4%
RSI (14)Momentum oscillator 0–10033.254.5
Avg Volume (50D)Average daily shares traded192K34.9M
HIMS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricTRNR logoTRNRInteractive Stren…HIMS logoHIMSHims & Hers Healt…
Analyst RatingConsensus buy/hold/sellHold
Price TargetConsensus 12-month target$29.67
# AnalystsCovering analysts19
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

HIMS leads in 3 of 6 categories (Income & Cash Flow, Total Returns). TRNR leads in 1 (Valuation Metrics). 1 tied.

Best OverallHims & Hers Health, Inc. (HIMS)Leads 3 of 6 categories
Loading custom metrics...

TRNR vs HIMS: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is TRNR or HIMS a better buy right now?

For growth investors, Interactive Strength Inc.

(TRNR) is the stronger pick with 459. 3% revenue growth year-over-year, versus 59. 0% for Hims & Hers Health, Inc. (HIMS). Hims & Hers Health, Inc. (HIMS) offers the better valuation at 50. 3x trailing P/E (51. 5x forward), making it the more compelling value choice. Analysts rate Hims & Hers Health, Inc. (HIMS) a "Hold" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — TRNR or HIMS?

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -100. 0% for Interactive Strength Inc. (TRNR). Over 10 years, the gap is even starker: HIMS returned +161. 9% versus TRNR's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — TRNR or HIMS?

By beta (market sensitivity over 5 years), Hims & Hers Health, Inc.

(HIMS) is the lower-risk stock at 2. 40β versus Interactive Strength Inc. 's 2. 40β — meaning TRNR is approximately 0% more volatile than HIMS relative to the S&P 500. On balance sheet safety, Interactive Strength Inc. (TRNR) carries a lower debt/equity ratio of 165% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — TRNR or HIMS?

By revenue growth (latest reported year), Interactive Strength Inc.

(TRNR) is pulling ahead at 459. 3% versus 59. 0% for Hims & Hers Health, Inc. (HIMS). On earnings-per-share growth, the picture is similar: Interactive Strength Inc. grew EPS 1. 7% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, TRNR leads at 155. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — TRNR or HIMS?

Hims & Hers Health, Inc.

(HIMS) is the more profitable company, earning 5. 5% net margin versus -649. 3% for Interactive Strength Inc. — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HIMS leads at 5. 2% versus -542. 5% for TRNR. At the gross margin level — before operating expenses — HIMS leads at 59. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — TRNR or HIMS?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is TRNR or HIMS better for a retirement portfolio?

For long-horizon retirement investors, Hims & Hers Health, Inc.

(HIMS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+161. 9% 10Y return). Interactive Strength Inc. (TRNR) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HIMS: +161. 9%, TRNR: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between TRNR and HIMS?

These companies operate in different sectors (TRNR (Consumer Cyclical) and HIMS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

TRNR

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 69%
Run This Screen
Stocks Like

HIMS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform TRNR and HIMS on the metrics below

Revenue Growth>
%
(TRNR: 139.1% · HIMS: 28.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.